rs116144189

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_015488.5(PNKD):​c.939G>A​(p.Arg313Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.017 in 1,593,238 control chromosomes in the GnomAD database, including 287 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.013 ( 22 hom., cov: 32)
Exomes 𝑓: 0.017 ( 265 hom. )

Consequence

PNKD
NM_015488.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 3.42

Publications

4 publications found
Variant links:
Genes affected
PNKD (HGNC:9153): (PNKD metallo-beta-lactamase domain containing) This gene is thought to play a role in the regulation of myofibrillogenesis. Mutations in this gene have been associated with the movement disorder paroxysmal non-kinesigenic dyskinesia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]
CATIP-AS2 (HGNC:41079): (CATIP antisense RNA 2)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 2-218344525-G-A is Benign according to our data. Variant chr2-218344525-G-A is described in ClinVar as Benign. ClinVar VariationId is 334327.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=3.42 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0132 (2011/152312) while in subpopulation NFE AF = 0.0191 (1301/68022). AF 95% confidence interval is 0.0183. There are 22 homozygotes in GnomAd4. There are 955 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 2011 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PNKDNM_015488.5 linkc.939G>A p.Arg313Arg synonymous_variant Exon 9 of 10 ENST00000273077.9 NP_056303.3 Q8N490-1A0A024R415

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PNKDENST00000273077.9 linkc.939G>A p.Arg313Arg synonymous_variant Exon 9 of 10 1 NM_015488.5 ENSP00000273077.4 Q8N490-1

Frequencies

GnomAD3 genomes
AF:
0.0132
AC:
2011
AN:
152194
Hom.:
22
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00401
Gnomad AMI
AF:
0.0175
Gnomad AMR
AF:
0.0134
Gnomad ASJ
AF:
0.0262
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00496
Gnomad FIN
AF:
0.0166
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0191
Gnomad OTH
AF:
0.0124
GnomAD2 exomes
AF:
0.0134
AC:
2868
AN:
213854
AF XY:
0.0135
show subpopulations
Gnomad AFR exome
AF:
0.00387
Gnomad AMR exome
AF:
0.0110
Gnomad ASJ exome
AF:
0.0244
Gnomad EAS exome
AF:
0.000188
Gnomad FIN exome
AF:
0.0183
Gnomad NFE exome
AF:
0.0179
Gnomad OTH exome
AF:
0.0169
GnomAD4 exome
AF:
0.0174
AC:
25093
AN:
1440926
Hom.:
265
Cov.:
31
AF XY:
0.0173
AC XY:
12358
AN XY:
714896
show subpopulations
African (AFR)
AF:
0.00275
AC:
91
AN:
33144
American (AMR)
AF:
0.0104
AC:
425
AN:
40886
Ashkenazi Jewish (ASJ)
AF:
0.0230
AC:
590
AN:
25650
East Asian (EAS)
AF:
0.000103
AC:
4
AN:
38818
South Asian (SAS)
AF:
0.00509
AC:
425
AN:
83460
European-Finnish (FIN)
AF:
0.0174
AC:
905
AN:
51896
Middle Eastern (MID)
AF:
0.0164
AC:
94
AN:
5740
European-Non Finnish (NFE)
AF:
0.0196
AC:
21589
AN:
1101720
Other (OTH)
AF:
0.0163
AC:
970
AN:
59612
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
1338
2676
4015
5353
6691
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
816
1632
2448
3264
4080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0132
AC:
2011
AN:
152312
Hom.:
22
Cov.:
32
AF XY:
0.0128
AC XY:
955
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00399
AC:
166
AN:
41562
American (AMR)
AF:
0.0134
AC:
205
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0262
AC:
91
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00497
AC:
24
AN:
4830
European-Finnish (FIN)
AF:
0.0166
AC:
176
AN:
10618
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0191
AC:
1301
AN:
68022
Other (OTH)
AF:
0.0123
AC:
26
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
94
188
283
377
471
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0173
Hom.:
35
Bravo
AF:
0.0120
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Feb 25, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 12, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 06, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Paroxysmal nonkinesigenic dyskinesia 1 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Paroxysmal nonkinesigenic dyskinesia Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.35
CADD
Benign
14
DANN
Benign
0.86
PhyloP100
3.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116144189; hg19: chr2-219209248; API